Search research articles
Contact Us
Filters
Showing results (291-300 of 359) with videos related to
Page
of 36
Sort By:
Orphanet Journal of Rare Diseases
|
August 4, 2021
Long-term efficacy and safety of sapropterin in patients who initiated sapropterin at < 4 years of age with phenylketonuria: results of the 3-year extension of the SPARK open-label, multicentre, randomised phase IIIb trial
Ania C Muntau, Alberto Burlina, François Eyskens, et al.
Orphanet Journal of Rare Diseases
|
July 24, 2019
Clinical burden of illness in patients with phenylketonuria (PKU) and associated comorbidities - a retrospective study of German health insurance claims data
K F Trefz, A C Muntau, K M Kohlscheen, et al.
Circulation
|
September 19, 2001
Randomized comparison of coronary stent implantation under ultrasound or angiographic guidance to reduce stent restenosis (OPTICUS Study)
H Mudra, C di Mario, P de Jaegere, et al.
BMC Pediatrics
|
November 13, 2024
Homozygous splice-site variant in ENPP1 underlies generalized arterial calcification of infancy
Hafiza Noor Ul Ayan, Yvonne Nitschke, Abdul Razzaq Mughal, et al.
Journal of Inherited Metabolic Disease
|
September 5, 2024
Long-term safety of sapropterin in paediatric and adult individuals with phenylalanine hydroxylase deficiency: Final results of the Kuvan® Adult Maternal Paediatric European Registry multinational observational study
François Feillet, Jean-Baptiste Arnoux, María Bueno Delgado, et al.
Journal of the American College of Cardiology
|
June 1, 1996
Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators
L K Newby, W R Rutsch, R M Califf, et al.
Seminars in Interventional Cardiology : SIIC
|
December 1, 1996
Clinical and angiographic outcome of elective stent implantation in small coronary vessels: an analysis of the BENESTENT trial
D Keane, A J Azar, P de Jaegere, et al.
The American Journal of Cardiology
|
February 8, 2005
Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy)
Pedro A Lemos, Patrick W Serruys, Pim de Feyter, et al.
Diabetes Care
|
June 26, 2021
Diabetes With Multiple Autoimmune and Inflammatory Conditions Linked to an Activating SKAP2 Mutation
Niklas Rutsch, Chester E Chamberlain, Wesley Dixon, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 6, 2021
Ectopic Calcification and Hypophosphatemic Rickets: Natural History of ENPP1 and ABCC6 Deficiencies
Carlos R Ferreira, Kristina Kintzinger, Mary E Hackbarth, et al.
Page
of 36
Search research articles
Search
Showing results (291-300 of 359) with videos related to
Sort By:
Page
of 36
Orphanet Journal of Rare Diseases
|
August 4, 2021
Long-term efficacy and safety of sapropterin in patients who initiated sapropterin at < 4 years of age with phenylketonuria: results of the 3-year extension of the SPARK open-label, multicentre, randomised phase IIIb trial
Ania C Muntau, Alberto Burlina, François Eyskens, et al.
Orphanet Journal of Rare Diseases
|
July 24, 2019
Clinical burden of illness in patients with phenylketonuria (PKU) and associated comorbidities - a retrospective study of German health insurance claims data
K F Trefz, A C Muntau, K M Kohlscheen, et al.
Circulation
|
September 19, 2001
Randomized comparison of coronary stent implantation under ultrasound or angiographic guidance to reduce stent restenosis (OPTICUS Study)
H Mudra, C di Mario, P de Jaegere, et al.
BMC Pediatrics
|
November 13, 2024
Homozygous splice-site variant in ENPP1 underlies generalized arterial calcification of infancy
Hafiza Noor Ul Ayan, Yvonne Nitschke, Abdul Razzaq Mughal, et al.
Journal of Inherited Metabolic Disease
|
September 5, 2024
Long-term safety of sapropterin in paediatric and adult individuals with phenylalanine hydroxylase deficiency: Final results of the Kuvan® Adult Maternal Paediatric European Registry multinational observational study
François Feillet, Jean-Baptiste Arnoux, María Bueno Delgado, et al.
Journal of the American College of Cardiology
|
June 1, 1996
Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators
L K Newby, W R Rutsch, R M Califf, et al.
Seminars in Interventional Cardiology : SIIC
|
December 1, 1996
Clinical and angiographic outcome of elective stent implantation in small coronary vessels: an analysis of the BENESTENT trial
D Keane, A J Azar, P de Jaegere, et al.
The American Journal of Cardiology
|
February 8, 2005
Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy)
Pedro A Lemos, Patrick W Serruys, Pim de Feyter, et al.
Diabetes Care
|
June 26, 2021
Diabetes With Multiple Autoimmune and Inflammatory Conditions Linked to an Activating SKAP2 Mutation
Niklas Rutsch, Chester E Chamberlain, Wesley Dixon, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 6, 2021
Ectopic Calcification and Hypophosphatemic Rickets: Natural History of ENPP1 and ABCC6 Deficiencies
Carlos R Ferreira, Kristina Kintzinger, Mary E Hackbarth, et al.
Page
of 36